{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T17:13:06Z","timestamp":1723482786258},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s40618-014-0115-4","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T09:34:33Z","timestamp":1403602473000},"page":"843-852","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in China"],"prefix":"10.1007","volume":"37","author":[{"given":"Linong","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhe","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"115_CR1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311\u2013321","journal-title":"Diabetes Res Clin Pract"},{"key":"115_CR2","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/diacare.20.11.1664","volume":"20","author":"XR Pan","year":"1997","unstructured":"Pan XR, Yang WY, Li GW, Liu J (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 20:1664\u20131669","journal-title":"Diabetes Care"},{"key":"115_CR3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090\u20131101","journal-title":"N Engl J Med"},{"key":"115_CR4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T et al (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310:948\u2013959","journal-title":"JAMA"},{"key":"115_CR5","doi-asserted-by":"crossref","unstructured":"The Emerging Risk Factors Collaboration (2010) Diabetes mellitus, fasting blood glucose concentration and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lacent 26(375):2215\u20132222","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"115_CR6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977\u2013986","journal-title":"N Engl J Med"},{"key":"115_CR7","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643\u20132653","journal-title":"N Engl J Med"},{"key":"115_CR8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837\u2013853","journal-title":"Lancet"},{"key":"115_CR9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"issue":"358","key":"115_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"7","author":"PL-AH Gaede","year":"2008","unstructured":"Gaede PL-AH, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 7(358):580\u2013591","journal-title":"N Engl J Med"},{"issue":"360","key":"115_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"8","author":"WAC Duckworth","year":"2009","unstructured":"Duckworth WAC, Moritz T, Reda D, Emanuele N, Reaven PD et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 8(360):129\u2013139","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"115_CR12","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.2337\/dc09-S339","volume":"32","author":"SR Heller","year":"2009","unstructured":"Heller SR (2009) A summary of the advance trial. Diabetes Care 32(Suppl 2):S357\u2013S361","journal-title":"Diabetes Care"},{"issue":"358","key":"115_CR13","first-page":"2560","volume":"12","author":"AMS Patel","year":"2008","unstructured":"Patel AMS, Chalmers J, Neal B, Billot L, Woodward M et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 12(358):2560\u20132572","journal-title":"N Engl J Med"},{"key":"115_CR14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","volume":"371","author":"G Li","year":"2008","unstructured":"Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q et al (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371:1783\u20131789","journal-title":"Lancet"},{"key":"115_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacc.2008.10.008","volume":"53","author":"JS Skyler","year":"2009","unstructured":"Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA et al (2009) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 53:298\u2013304","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"115_CR16","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association (2013) Standards of medical care in diabetes-2013. Diabetes Care 36(Suppl 1):S11\u2013S66","journal-title":"Diabetes Care"},{"key":"115_CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40265-013-0023-5","volume":"73","author":"JM Chehade","year":"2013","unstructured":"Chehade JM, Gladysz M, Mooradian AD (2013) Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs 73:327\u2013339","journal-title":"Drugs"},{"key":"115_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc10-1206","volume":"34","author":"S Colagiuri","year":"2011","unstructured":"Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K (2011) Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 34:145\u2013150","journal-title":"Diabetes Care"},{"key":"115_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"115_CR20","first-page":"s4","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association (2013) Executive summary: standards of medical care in diabetes-2013. Diabetes Care 36(Suppl 1):s4\u2013s10","journal-title":"Diabetes Care"},{"key":"115_CR21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837\u2013853","journal-title":"Lancet"},{"key":"115_CR22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/1753-0407.12082","volume":"6","author":"J Weng","year":"2013","unstructured":"Weng J, Yang X (2013) Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complications. J Diabetes 6:30\u201332","journal-title":"J Diabetes"},{"key":"115_CR23","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/ndt\/gfn149","volume":"23","author":"X Yang","year":"2008","unstructured":"Yang X, So WY, Ma R, Ko G, Kong A, Lam C et al (2008) Effects of albuminuria and renal dysfunction on development of dyslipidaemia in type 2 diabetes\u2013the Hong Kong Diabetes Registry. Nephrol Dial Transplant 23:2834\u20132840","journal-title":"Nephrol Dial Transplant"},{"key":"115_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2840-6-37","volume":"6","author":"X Yang","year":"2007","unstructured":"Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW et al (2007) Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients: the Hong Kong diabetes registry. Cardiovasc Diabetol 6:37","journal-title":"Cardiovasc Diabetol"},{"key":"115_CR25","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc08-1079","volume":"31","author":"X Yang","year":"2008","unstructured":"Yang X, Ko GT, So WY, Ma RC, Kong AP, Lam CW et al (2008) Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry. Diabetes Care 31:2294\u20132300","journal-title":"Diabetes Care"},{"key":"115_CR26","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640\u20131645","journal-title":"Circulation"},{"key":"115_CR27","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.96.24.13656","volume":"96","author":"I Shimomura","year":"1999","unstructured":"Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL (1999) Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96:13656\u201313661","journal-title":"Proc Natl Acad Sci USA"},{"key":"115_CR28","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00125-007-0752-7","volume":"50","author":"R Han","year":"2007","unstructured":"Han R, Lai R, Ding Q, Wang Z, Luo X, Zhang Y et al (2007) Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia 50:1960\u20131968","journal-title":"Diabetologia"},{"key":"115_CR29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1463-1326.2011.01551.x","volume":"14","author":"XL Yang","year":"2012","unstructured":"Yang XL, Ma RC, So WY, Kong AP, Xu G, Chan JC (2012) Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings\u2013what, why and how? Diabetes Obes Metab 14:579\u2013585","journal-title":"Diabetes Obes Metab"},{"key":"115_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1677\/ERC-07-0266","volume":"15","author":"X Yang","year":"2008","unstructured":"Yang X, So WY, Ma RC, Ko GT, Kong AP, Wang Q et al (2008) Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. Endocr Relat Cancer 15:597\u2013607","journal-title":"Endocr Relat Cancer"},{"key":"115_CR31","doi-asserted-by":"crossref","first-page":"e39513","DOI":"10.1371\/journal.pone.0039513","volume":"7","author":"W Yang","year":"2012","unstructured":"Yang W, Zhao W, Xiao J, Li R, Zhang P, Kissimova-Skarbek K et al (2012) Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS ONE 7:e39513","journal-title":"PLoS ONE"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0115-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0115-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0115-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T08:35:03Z","timestamp":1597998903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0115-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["115"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0115-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]}}}